Stephanie Poulain
Lille, 59000, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 49 publications
Waldenström's macroglobulinemia: The LYSA pragmatic guidelines.
Journal: European journal of cancer (Oxford, England : 1990)
Published: June 28, 2025
Late toxicity and long-term efficacy of first-line bendamustine and rituximab combination in patients with Waldenström macroglobulinemia.
Journal: Leukemia
Published: June 03, 2025
Targeted therapies overcome the poor prognosis of stereotyped Subset#2 chronic lymphocytic leukemia : a real-world multicentric study.
Journal: Leukemia
Published: October 31, 2024
Six-year follow-up of phase II study exploring chemo-free treatment association with idelalisib and obinutuzumab in symptomatic relapsed/ refractory patients with Waldenström's macroglobulinemia.
Journal: Annals of hematology
Published: August 26, 2024
Genomic profiling of mycosis fungoides identifies patients at high risk of disease progression.
Journal: Blood advances
Published: December 12, 2023
Long-term results of Waldenström macroglobulinaemia treatment by bendamustine and rituximab: A study on behalf of the French Innovative Leukemia Organization (FILO).
Journal: British journal of haematology
Published: December 04, 2023
Single-cell genomics highlight MYC-associated metabolic activation and altered cell interactions in T-prolymphocytic leukemia progression.
Journal: Nature communications
Published: November 15, 2023
New developments in the diagnosis and characterization of Waldenström's macroglobulinemia.
Journal: Expert review of hematology
Published: October 31, 2023
Report of Consensus Panel 3 from the 11th International workshop on Waldenström's Macroglobulinemia: Recommendations for molecular diagnosis in Waldenström's Macroglobulinemia.
Journal: Seminars in hematology
Published: March 23, 2023
The Broad Spectrum of TP53 Mutations in CLL: Evidence of Multiclonality and Novel Mutation Hotspots.
The Broad Spectrum of TP53 Mutations in CLL: Evidence of Multiclonality and Novel Mutation Hotspots.
Journal: Human mutation
Published: December 20, 2022
Successful and safe response to ibrutinib alone in treating relapsed Waldenström macrogobulinemia and related acquired von Willebrand syndrome: an option to consider.
Journal: Leukemia & lymphoma
Published: December 17, 2022
Last Updated: 09/26/2026